SEMAGLUTIDE & TIRZEPATIDE WEIGHT LOSS PROGRAM

MEDICAL CONCIERGE PRACTICE IS FULL CURRENTLY.
WILL CONSIDER ARIZONA RESIDENTS ON A CASE BY CASE
PLEASE EMAIL REQUEST AND STATE YOU ARE AN ARIZONA RESIDENT - mjatoi[at]drjatoidirectprimarycare.com

WEIGHT LOSS INTRO PACKAGE *Initial 8 weeks*
  • Initial consultation via telemedicine with physician to create plan and goals – 8 weeks of prescription writing
  • 8 weeks of concierge medical weight loss – direct texting / messaging access to Dr. Jatoi for support in your journey
  • Work on what options are best for you
    • Semaglutide
    • Tirzepatide
  • Help manage side effects to medications
  • This doesn’t cover medication cost, this is in addition to medication cost outlined below
FOLLOW UP PACKAGE *Every 8 weeks thereafter*
    • Renew prescriptions for 8, 10, 12 weeks – prices below
    • Continued support for the journey of weight loss
    • Individualized plans on how to achieve goal weight
    • Safe and effective monitoring, draw labs if necessary
    • Continued 8 weeks of concierge medical weight loss support directly with Dr. Jatoi
    • This doesn’t cover medication cost, this is in addition to medication cost outlined below
 
 
SEMAGLUTIDE INFORMATION (GLP-1)
  • BENEFITS
  • Decreased appetite and cravings
  • Weight loss
  • In 2 months could lose up to 15-25 pounds, in 4 months could lose up to 25-50 pounds or more
  • Compounded formulas are compounded with medication to help alleviate side effects of nausea
  • Injections are once weekly
  • Can repeat program as many times as you wish
 
COMMON SIDE EFFECTS
  • Nausea
  • GERD
  • Constipation
 
RISK OF THYROID C-CELL TUMORS
  • If you or any family member has been diagnosed with Multiple Endocrine Neoplasia Syndrome Type 2 or medullary thyroid cancer you should not take Semaglutide
 
INFORMATION
  • Semaglutide simulates naturally occurring hormone that acts on appetite centers in the brain and in the gut, producing feelings of satiety. Over 2,000 participants at 129 center in 16 countries who injected weekly vs placebo for the trial lost 15% of their body weight compared to less than 3% with the placebo group.
 
TIRZEPATIDE INFORMATION (GLP-1 + GIP)
  • BENEFITS
  • Decreased appetite and cravings
  • Weight loss
  • Clinical trials showed 15% to 30% weight loss depending on doses
  • Compounded formulas are compounded with medication to help alleviate side effects of nausea
  • Injections are once weekly
  • Can repeat program as many times as you wish
 
COMMON SIDE EFFECTS
  • Nausea
  • Constipation
  • Indigestion
 
RISK OF THYROID C-CELL TUMORS
  • If you or any family member has been diagnosed with Multiple Endocrine Neoplasia Syndrome Type 2 or medullary thyroid cancer you should not take Semaglutide
 
INFORMATION
  • Tirzepatide is a combination glucagon-like peptide 1 (GLP-1) receptor AND glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that acts on areas of brain that regulate food intake and appetite. 2,539 adult clinical trial showed weight loss from 15% to 35% weight loss versus placebo group.
 

Need Help or Have Any Question?

We are always here to answer all your questions, feel free to contact us any time we will get back to you as soon as possible.